News
Productivity improvements help accelerate design workflows and collaboration Faster composite design and manufacturing while maintaining high precision and quality Advanced simulation and AI ...
PTC will demonstrate cloud-native MBD in Onshape with Aura Aero, a leader in sustainable aviation, at Aura Aero's display at ...
Productivity improvements help accelerate design workflows and collaboration Faster composite design and manufacturing while maintaining high precision and quality Advanced simulation and AI-driven ...
BOSTON, June 4, 2025 /PRNewswire/ --PTC (NASDAQ: PTC) today announced the latest version of its Creo ® computer-aided design (CAD) solution, built to help manufacturers deliver their best designs ...
For more on Creo 12, read this blog from Brian Thompson, PTC's General Manager of Creo: Creo 12 Helps Deliver Your Best Designs in Less Time. PTC will demonstrate Creo 12 at the International ...
With a market cap of $20.7 billion, PTC Inc. (PTC) operates as a software company in the Americas and internationally. Headquartered in Boston, Massachusetts, the company offers a comprehensive ...
In terms of pipeline readiness for future product expansions, PTC has already integrated AI features into the Creo CAD platform (design assistance and generative modeling). PTC is also expanding ...
In addition to demonstrating cloud-native MBD in Onshape with Aura Aero at Zone B4, PTC will demonstrate the newest version of its Creo computer-aided design solution and its agentic AI solutions ...
Cero Therapeutics says FDA granted Orphan Drug Designation for its lead drug candidate CER-1236 for the treatment of acute myeloid leukemia. Cero Therapeutics shares surge on the news. Last Chance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results